Dicot Pharma AB (OM: DICOT)
Health Care · Pharmaceuticals · SE
Skr0.22
+2.86% today · -78.2% 1Y
Dicot Pharma AB (OM: DICOT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $76.92M.
Over the last twelve months the share price has lost 78.2%, trading between 0.18 and 1.18.
Tweenvest scores Dicot Pharma AB across four factors: quality 26/100. Its strongest factor is quality.
DICOT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $76.92M
- Revenue (TTM)
- $0.00
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.86
- 52-week high
- Skr1.18
- 52-week low
- Skr0.18
- Avg volume (3M)
- —
- Shares outstanding
- 3.47B
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,231.78 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.81 | -0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.